Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

LifeBond

Explore full profile

Manufactures medical devices for biosurgery and tissue repair in an effort to save lives and reduce postoperative complications

Keisarya, IsraelFounded 2007Biotech & Life Sciences
Valuation $50–100M Last recorded · 2020
Total funding $50–100M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for LifeBond and the history behind them.

About LifeBond

LifeBond is a medical technology company specializing in advanced hemostatic solutions designed to control surgical bleeding and improve patient outcomes. Operating in the healthcare and medical devices market, LifeBond serves hospitals, surgical centers, and healthcare professionals who require reliable and effective bleeding control products. The company's business model revolves around the development, manufacturing, and distribution of its proprietary hemostatic products, which generate revenue through direct sales and partnerships with medical distributors. LifeBond's innovative products are designed to enhance surgical safety, reduce complications, and improve overall patient care, making it a valuable player in the medical technology industry.

Source: Dealroom company data

At a glance

Status
Acquired
Founded
2007
Headquarters
Keisarya, Israel
Open positions
None listed
Dealroom signal
58.8/100
Industry
Health
Sub-industry
BioTechnology, Medical Devices
Sector
Biotech & Life Sciences, Biotechnology, Surgery, Biomaterials, Tissue Engineering, Soft Tissues, Chemical, Hospital, Tech for Hospitals and Clinics, Biotech and Pharma, Hard Tech
Business model
Manufacturing

Funding history

6 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
ACQUISITIONOther financing Jan 2020 $60M $60M C. R. Bard ↗
SERIES DOther financing Aug 2015 $27M $108M Pitango Venture Capital · Giza Venture Capital · GlenRock Israel · BizTEC —
Showing the latest 2 of 6 recorded eventsBook a demo for the full funding history →

Growth signals

LifeBond website traffic

Latest recorded traffic for LifeBond is 170 monthly website visits.

Latest monthly visits170
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

9 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed1 investor entered at this stage

  • Trendlines Group

Series A4 investors entered at this stage

Series B and later3 investors entered at this stage

  • Giza Venture Capital
  • Aurum Ventures
  • BizTEC

Other known investors1 additional known investor

  • C. R. Bard
Team profiled 4 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇮🇱 Israel · Keisarya HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about LifeBond on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See LifeBond’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.